Lupin receives FDA approval for Lotrel generic
BALTIMORE The Food and Drug Administration has approved a generic hypertension drug made by India-based Lupin Pharmaceuticals, Lupin announced Monday.
The FDA approved Lupin’s amlodipine/benazepril capsules in the 2.5-mg/10-mg, 5-mg/10-mg, 5-mg/20-mg and 10-mg/20-mg strengths.
The capsules are a generic version of Novartis’ Lotrel. Generic and branded versions of the drug had sales of $1.1 billion during the 12-month period ending in September 2009, according to IMS Health.